Caribou Biosciences (NasdaqGS:CRBU) Update / Briefing November 03, 2025 08:00 AM ET Speaker0Good morning and welcome to the webcast to report and discuss clinical updates from both of Caribou's off-the-shelf CAR-T cell therapy programs. At this time, all participants are in listen-only mode. Please be aware that today's webcast is being recorded. I would now like to introduce the first speaker, Dr. Peggy Verwald, Senior Director of Investor Relations and Corporate Communications. You may begin.Speaker1Thank ...